
The Pleiotropic Effects of GLP-1 Receptor Agonists: Expanding Therapeutic Horizons Beyond Glycemic Control
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the management of type 2 diabetes mellitus (T2DM) due to their potent glucose-lowering effects, favorable impact on body weight, and relatively low risk of hypoglycemia. However, the […]